Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidating Financial Information (Condensed Consolidating Statement of Cash Flows) (Details)

v3.19.3.a.u2
Condensed Consolidating Financial Information (Condensed Consolidating Statement of Cash Flows) (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Nov. 02, 2019
Nov. 03, 2018
Nov. 02, 2019
Nov. 03, 2018
Cash flows from operating activities:        
Net income (loss) $ 2 $ 62 $ 224 $ 358
Impairment, restructuring and other costs 13 3 16 39
Settlement charges 12 23 12 73
Equity in loss (earnings) of subsidiaries 0 0 0 0
Dividends received from subsidiaries     0 0
Depreciation and amortization     725 718
Gains on sale of real estate (17) (42) (67) (111)
Change in assets, liabilities and other items not separately identified     (738) (648)
Net cash provided by operating activities     172 429
Cash flows from investing activities:        
Purchase of property and equipment and capitalized software, net of dispositions     (739) (556)
Other, net     10 7
Net cash used by investing activities     (729) (549)
Cash flows from financing activities:        
Debt repaid     (42) (361)
Debt repaid, including debt issuance costs     (45)  
Dividends paid     (349) (347)
Issuance of common stock, net of common stock acquired     5  
Issuance or common stock     6 41
Proceeds from noncontrolling interest     0 7
Intercompany activity, net     0 0
Other, net     49 44
Net cash provided (used) by financing activities     (340) (616)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect     (897) (736)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, beginning of period     1,248 1,513
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, end of period 351 777 351 777
Parent        
Cash flows from operating activities:        
Net income (loss) 2 62 224 368
Impairment, restructuring and other costs 0 0 0 0
Settlement charges 0 0 0 5
Equity in loss (earnings) of subsidiaries 3 (59) (212) (362)
Dividends received from subsidiaries     819 689
Depreciation and amortization     0 0
Gains on sale of real estate 0 0 0 0
Change in assets, liabilities and other items not separately identified     (99) (191)
Net cash provided by operating activities     732 509
Cash flows from investing activities:        
Purchase of property and equipment and capitalized software, net of dispositions     0 0
Other, net     0 0
Net cash used by investing activities     0 0
Cash flows from financing activities:        
Debt repaid       0
Debt repaid, including debt issuance costs     0  
Dividends paid     (349) (347)
Issuance of common stock, net of common stock acquired     5  
Issuance or common stock       41
Proceeds from noncontrolling interest       0
Intercompany activity, net     (1,161) (803)
Other, net     (74) (83)
Net cash provided (used) by financing activities     (1,579) (1,192)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect     (847) (683)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, beginning of period     889 1,109
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, end of period 42 426 42 426
Subsidiary Issuer        
Cash flows from operating activities:        
Net income (loss) (213) (166) (422) (289)
Impairment, restructuring and other costs 1 0 1 0
Settlement charges 0 8 0 24
Equity in loss (earnings) of subsidiaries 125 58 264 (51)
Dividends received from subsidiaries     0 0
Depreciation and amortization     251 250
Gains on sale of real estate (8) (41) (32) (83)
Change in assets, liabilities and other items not separately identified     (139) 115
Net cash provided by operating activities     (77) (34)
Cash flows from investing activities:        
Purchase of property and equipment and capitalized software, net of dispositions     (179) (98)
Other, net     (2) (15)
Net cash used by investing activities     (181) (113)
Cash flows from financing activities:        
Debt repaid       (310)
Debt repaid, including debt issuance costs     (45)  
Dividends paid     0 0
Issuance of common stock, net of common stock acquired     0  
Issuance or common stock       0
Proceeds from noncontrolling interest       0
Intercompany activity, net     239 378
Other, net     73 74
Net cash provided (used) by financing activities     267 142
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect     9 (5)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, beginning of period     64 79
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, end of period 73 74 73 74
Other Subsidiaries        
Cash flows from operating activities:        
Net income (loss) 85 167 370 692
Impairment, restructuring and other costs 12 3 15 39
Settlement charges 12 15 12 44
Equity in loss (earnings) of subsidiaries 0 0 0 0
Dividends received from subsidiaries     0 0
Depreciation and amortization     474 468
Gains on sale of real estate (9) (1) (35) (28)
Change in assets, liabilities and other items not separately identified     (500) (571)
Net cash provided by operating activities     336 644
Cash flows from investing activities:        
Purchase of property and equipment and capitalized software, net of dispositions     (560) (458)
Other, net     12 (29)
Net cash used by investing activities     (548) (487)
Cash flows from financing activities:        
Debt repaid       (1)
Debt repaid, including debt issuance costs     0  
Dividends paid     (819) (689)
Issuance of common stock, net of common stock acquired     0  
Issuance or common stock       0
Proceeds from noncontrolling interest       7
Intercompany activity, net     922 425
Other, net     50 53
Net cash provided (used) by financing activities     153 (205)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect     (59) (48)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, beginning of period     295 325
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, end of period 236 277 236 277
Consolidating Adjustments        
Cash flows from operating activities:        
Net income (loss) 128 (1) 52 (413)
Impairment, restructuring and other costs 0 0 0 0
Settlement charges 0 0 0 0
Equity in loss (earnings) of subsidiaries (128) 1 (52) 413
Dividends received from subsidiaries     (819) (689)
Depreciation and amortization     0 0
Gains on sale of real estate 0 0 0 0
Change in assets, liabilities and other items not separately identified     0 (1)
Net cash provided by operating activities     (819) (690)
Cash flows from investing activities:        
Purchase of property and equipment and capitalized software, net of dispositions     0 0
Other, net     0 51
Net cash used by investing activities     0 51
Cash flows from financing activities:        
Debt repaid       (50)
Debt repaid, including debt issuance costs     0  
Dividends paid     819 689
Issuance of common stock, net of common stock acquired     0  
Issuance or common stock       0
Proceeds from noncontrolling interest       0
Intercompany activity, net     0 0
Other, net     0 0
Net cash provided (used) by financing activities     819 639
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect     0 0
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, beginning of period     0 0
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, end of period $ 0 $ 0 $ 0 $ 0